7th Annual Conference in Japan for Asian New Drug Development

Featured

Want to learn more about 7th Annual Conference in Japan for Asian New Drug Development? You've come to the right site!

Kihito Takahashi Head of R&D/Medical Affairs Hub Japan
Swedish Orphan Biovitrium (SOBI) Japan, Japan
Tetsuomi Takano, RPh Editor-in-Chief
Drug R&D Expert, Japan
Yuko Kikuchi, MS, RPh Senior Director, Asia Regulatory Affairs
Eisai Co., Ltd., Japan
Koichi Miyazaki, PhD Senior Director, Group IV, Oncology Clinical Development Department
Daiichi Sankyo Co., Ltd., Japan
Junichi Nishino, MSc, RPh Head, Regulatory Affairs Department
Otsuka Pharmaceutical Co., Ltd., Japan
Yoshihiko Ono, RPh Regulatory Executive Advisor, Japan Development
MSD K.K., Japan
Yasuto Otsubo Review Director, Office of New Drug II
Pharmaceuticals and Medical Devices Agency (PMDA), Japan
Akio Uemura, PhD Senior Advisor
AU Consulting, Co., Japan
Yoshiaki Uyama, PhD, RPh Associate Executive Director
Pharmaceuticals and Medical Devices Agency (PMDA), Japan